<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03627585</url>
  </required_header>
  <id_info>
    <org_study_id>ICA-CDRF-2016-02-055</org_study_id>
    <nct_id>NCT03627585</nct_id>
  </id_info>
  <brief_title>Reprogramming to Prevent Progressive Pacemaker-induced Remodelling</brief_title>
  <acronym>PPPR</acronym>
  <official_title>Reprogramming to Prevent Progressive Pacemaker-Induced Remodelling</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leeds</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Leeds</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim is to provide evidence of the long-term benefits of personalised pacemaker
      programming on heart function and battery longevity.

      This will be achieved by showing in a single centre, phase II, double-blind, randomised,
      placebo-controlled trial that reducing the amount of pacemaker beats to a minimum reverses
      these changes and extends battery life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients (n=70) with long-term (&gt;2 years) permanent pacemakers with avoidable RV pacing will
      be invited to participate in a single-centre, phase II, randomised, double-blind
      placebo-controlled trial of optimised pacing programming versus standard care. Those
      randomised to the intervention arm will have personalised programming to avoid right
      ventricular pacing, whilst those allocated to standard care will have no programming changes
      made. All participants will be invited back at 6 months for a repeat echocardiogram, quality
      of life assessment (EQ-5D-5L), blood tests and pacemaker check.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Actual">August 6, 2019</completion_date>
  <primary_completion_date type="Actual">January 6, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Left ventricular ejection fraction</measure>
    <time_frame>6 months</time_frame>
    <description>Left ventricular functional measure using either 3D volumes or Simpson's Biplane obtained from echocardiographic images.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>LV remodelling parameters</measure>
    <time_frame>6 months</time_frame>
    <description>left ventricular end diastolic and systolic volumes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Measures</measure>
    <time_frame>6 months</time_frame>
    <description>EQ-5D, Minnesota living with Heart Failure Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Battery Longevity</measure>
    <time_frame>6 months</time_frame>
    <description>Impedance</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">91</enrollment>
  <condition>Left Ventricular Dysfunction</condition>
  <condition>Heart Failure, Systolic</condition>
  <condition>Left Ventricular Failure</condition>
  <condition>Pacemaker; Complication, Mechanical</condition>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients received echocardiogram but no pacemaker reprogramming or personalisation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Personalised programming</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient will have tailored pacemaker programming based on echocardiographic findings, blood results, and symptoms in an attempt to minimise right ventricular pacing and extend battery longevity.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Personalised programming</intervention_name>
    <description>Reprogramming protocol already test in an observation cohort will be utilised which will direct physiologists to consider pacemaker mode, base rate, utilisation of rate response, hysteresis, sleep and rest rates as well as lead outputs.</description>
    <arm_group_label>Personalised programming</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic right ventricular bradycardia pacemaker implanted for at least 24 months

          -  Willing and able to give informed consent for the intervention

        Exclusion Criteria:

          -  Known poor imaging quality patients (details of patients excluded for this reason will
             be recorded)

          -  Patients with complete heart block and no reprogramming options
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Klaus Witte, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Leeds</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Harrogate District Foundation Trust</name>
      <address>
        <city>Harrogate</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leeds Teaching Hospitals NHS Trust</name>
      <address>
        <city>Leeds</city>
        <zip>LS1 3EX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>August 6, 2018</study_first_submitted>
  <study_first_submitted_qc>August 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2018</study_first_posted>
  <last_update_submitted>September 24, 2019</last_update_submitted>
  <last_update_submitted_qc>September 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Leeds</investigator_affiliation>
    <investigator_full_name>KK Witte</investigator_full_name>
    <investigator_title>Senior Lecturer in Cardiology</investigator_title>
  </responsible_party>
  <keyword>pacemaker</keyword>
  <keyword>heart failure</keyword>
  <keyword>left ventricular dysfunction</keyword>
  <keyword>bradycardia</keyword>
  <keyword>remodelling</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Ventricular Dysfunction</mesh_term>
    <mesh_term>Ventricular Dysfunction, Left</mesh_term>
    <mesh_term>Heart Failure, Systolic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

